Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1581)
  2. Meeting Abstract (783)
  3. Book Section (104)
  4. Review (68)
  5. Editorial (58)
  6. Research Letter (42)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1667)
  2. Survivorship Research (1183)
  3. Solid Tumor Oncology Division (1036)
  4. Department of Pathology and Laboratory Medicine (945)
  5. Surgery (938)
  6. Melanoma and Immunotherapeutics Service (783)

More Groups

People
  1. Klaus Busam (688)
  2. Daniel Coit (542)
  3. Allan Halpern (396)
  4. Michael Postow (362)
  5. Alexander Shoushtari (244)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (53)
  2. 2024 (136)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (264)
  2. Annals of Surgical Oncology (220)
  3. Journal of the American Academy of Dermatology (122)
  4. Journal of Investigative Dermatology (80)
  5. Modern Pathology (66)
  6. International Journal of Radiation Oncology, Biology, Physics (64)

More Publications

Publishers
  1. Springer (340)
  2. American Society of Clinical Oncology (279)
  3. Elsevier Inc. (227)
  4. Lippincott Williams & Wilkins (224)
  5. Wiley Blackwell (160)
  6. American Association for Cancer Research (157)

More Publishers

Results (2732)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermoscopic and clinical image dataset for AI research in dermatology
    Meeting Abstract

    Gui, H.; Chiou, A.; Omiye, J.; Ran Cai, Z.; Ko, J.; Swetter, S.; Gastman, B.; Arbesman, J.; Bailin, P.; Muralidharan, V.; more...
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Comparison of clinical outcomes of stable disease with confirmed tumor reduction and RECIST partial response for tebentafusp in metastatic uveal melanoma (mUM)
    Meeting Abstract

    Ikeguchi, A.; Sato, T.; Butler, M. O.; Carvajal, R. D.; Sacco, J. J.; Shoushtari, A. N.; Hassel, J. C.; Nathan, P. D.; Piulats, J. M.; Johnson, D. B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Biomarker analysis and updated clinical outcomes: Neoadjuvant systemic treatment (NST) with nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma
    Meeting Abstract

    Burton, E. M.; Wani, K. M.; Milton, D. R.; Segura, R. L.; Tetzlaff, M.; Ross, M. I.; Postow, M. A.; Glitza, I. C.; Wong, M. K. K.; Diab, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1/2 study to investigate the safety and efficacy of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Hamid, O.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P. N.; Ramsingh, G.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • First-line treatment preferences for advanced melanoma among oncologists and patients in the US: A discrete choice experiment
    Meeting Abstract

    Postow, M. A.; Burgos, G.; DeCongelio, M.; Palaia, J.; Ejzykowicz, F.; Patel, D.; Rosenblatt, L.; Modi, K.; Pittman, Z.; Honomichl, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Warner, A. B.; Smithy, J. W.; Postow, M. A.; Panageas, K.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations
    Meeting Abstract

    Sewastianik, T.; Roy, C.; Halvey, P.; Montesion, M.; Jindal, A.; Garrity, S.; Lam, H.; Shapiro, G.; Vallaster, M. P.; Vincent, L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Standardizing radiologic reporting of response to improve the patient experience: Comparing response categories of RECIST 1.1 and a novel, real-world, standardized, oncologic response lexicon derived from clinical radiology reports
    Meeting Abstract

    Chen, M. F.; Ma, W.; Caravella, B. A.; Harada, G.; Gangai, N.; Grimaldi, G.; Waksmundzki, A.; Trevenen, W.; Kohlasch, K.; Reynolds, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save